Treatment of Pneumocystis jirovecii Pneumonia with Caspofungin and Clindamycin: An HIV Patient and Literature Review
dc.authorid | Inkaya, Ahmet Cagkan/0000-0001-7943-8715 | |
dc.contributor.author | Yilmaz, Gul Ruhsar | |
dc.contributor.author | Kaya, Onur | |
dc.contributor.author | Inkaya, Ahmet Cagkan | |
dc.contributor.author | Unal, Onur | |
dc.contributor.author | Temel, Esra Nurlu | |
dc.contributor.author | Akcam, Fusun Zeynep | |
dc.contributor.author | Cetin, Emel Sesli | |
dc.date.accessioned | 2024-08-04T20:11:43Z | |
dc.date.available | 2024-08-04T20:11:43Z | |
dc.date.issued | 2023 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | The first-line treatment for Pneumocystis jirovecii pneumonia (PCP) is trimethoprim-sulfamethoxazole (TMP-SMZ). However, some cases require alternative agents due to the side effects of TMP-SMZ. Treatment with TMP-SMZ was initiated in an HIV-positive patient with microbiologically confirmed PCP, who presented with acute renal failure on admission. On the third day of treatment, TMP-SMZ was discontinued due to worsening renal function. Subsequently, clindamycin was initiated in combination with caspofungin. Although caspofungin-based therapies were shown to be effective against Pneumocystis in animal models, clinical experience in humans is limited. The patient was treated successfully with clindamycin combined with caspofungin. | en_US |
dc.identifier.doi | 10.5578/flora.202401981 | |
dc.identifier.endpage | 144 | en_US |
dc.identifier.issn | 1300-932X | |
dc.identifier.issn | 2602-2842 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 139 | en_US |
dc.identifier.trdizinid | 1228184 | en_US |
dc.identifier.uri | https://doi.org/10.5578/flora.202401981 | |
dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/1228184 | |
dc.identifier.uri | https://hdl.handle.net/11616/92954 | |
dc.identifier.volume | 29 | en_US |
dc.identifier.wos | WOS:001258696800001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bilimsel Tip Yayinevi | en_US |
dc.relation.ispartof | Flora Infeksiyon Hastaliklari Ve Klinik Mikrobiyoloji Dergisi | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Words | en_US |
dc.subject | Pneumocystis jirovecii | en_US |
dc.subject | Clindamycin | en_US |
dc.subject | Caspofungin | en_US |
dc.title | Treatment of Pneumocystis jirovecii Pneumonia with Caspofungin and Clindamycin: An HIV Patient and Literature Review | en_US |
dc.type | Article | en_US |